Stay updated with breaking news from Mei pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts at StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a report issued on Tuesday. The brokerage set a “buy” rating on the stock. Other equities analysts have also issued research reports about the company. TheStreet lowered MEI Pharma from a “c-” rating to a “d+” rating in a […] ....
StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a note issued to investors on Monday. The firm set a “buy” rating on the stock. A number of other equities analysts have also recently issued reports on MEIP. Stifel Nicolaus reiterated a “hold” rating and issued a $7.00 price target […] ....
MEI Pharma (NASDAQ:MEIP – Free Report) had its price objective trimmed by Stifel Nicolaus from $8.00 to $7.00 in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has a hold rating on the stock. MEIP has been the topic of a number of other reports. StockNews.com downgraded shares of […] ....
MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of -13.70% and 100%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? ....
GreenWood Investors LLC, an investment management firm, released its annual 2023 investor letter. A copy of the same can be downloaded here. 2023 was excellent for the fund’s investors, thanks to the collaborative and constructive engagements, which added immense value to the performance. Despite that, the firm is still seeking more challenges to continue to drive […] ....